Cisplatin resistance involves a metabolic reprogramming through ROS and PGC-1α in NSCLC which can be overcome by OXPHOS inhibition
2019 · Free Radical Biology and Medicine · 207 citations
https://doi.org/10.1016/j.freeradbiomed.2019.03.009
A
Aránzazu García‐Grande
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
21
Papers
958
Citations
12
h-index
12
i10-index
Aránzazu García‐Grande is an academic researcher from Instituto de Investigación Sanitaria de Santiago. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Lung Cancer Treatments and Mutations & Immunotherapy and Immune Responses. The author has an h-index of 12, co-authored 18 publications.
ORCID: 0000-0001-5737-8918Papers by this author
worksResearch topics
topicsChat about Author
Papers
Chat
Click to start Chat